Credit Suisse Ag Burning Rock Biotech LTD Transaction History

Credit Suisse Ag

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$2.39 - $3.96 $1.98 Million - $3.27 Million	-826,547 Reduced 99.18%	6,821 $16,000
Q2 2022 Aug 12, 2022	BUY	$1.75 - $10.44 $1.46 Million - $8.7 Million	833,368 New	833,368 $2.43 Million
Q4 2021 Feb 14, 2022	SELL	$9.43 - $17.14 $584,311 - $1.06 Million	-61,963 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$17.37 - $27.92 $275,957 - $443,565	15,887 Added 34.48%	61,963 $1.11 Million
Q2 2021 Aug 16, 2021	BUY	$26.14 - $37.45 $1.2 Million - $1.73 Million	46,076 New	46,076 $1.36 Million

21.2K

Ticker BNR
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 105,188,000
Market Cap $705M
Description
Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

Stay updated on Credit Suisse Ag with notifications on news.